AbbVie has become the Official Pharmaceutical Partner of Major League Baseball (MLB) starting in the 2026 season, expanding its Striking Out Cancer campaign league-wide. For every strikeout recorded in MLB games, AbbVie will donate $20 to Stand Up To Cancer, up to $1 million per season, supporting cancer awareness and research. This initiative builds on a 2025 collaboration with the Chicago Cubs and aims to leverage baseball's platform to raise awareness and funds for cancer research throughout the season and key MLB events. The campaign highlights the connection between sport and science to inspire hope and action against cancer.
SkinMedica, part of Allergan Aesthetics under AbbVie, has launched a Regenerative Science Advisory Board composed of leading skin health experts to guide future innovation. The company also expanded its R&D facility in Irvine, California, integrating...
Big pharmaceutical companies are confronting a $300 billion loss in drug patents by 2030, prompting a surge in acquisitions of mid-size biotech firms with promising drug pipelines. In 2026, biopharma deal values are expected to exceed $250 billion, t...
